ClinicalTrials.Veeva

Menu

Arabic PRO Measures for Head and Neck Cancer Radiotherapy. (PROMs)

K

King Saud University

Status

Enrolling

Conditions

Oral Neoplasm
Nasopharyngeal Cancer
Oropharynx Cancer
Head and Neck Neoplasms
Tongue Cancer
Oral Cancer
Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma

Treatments

Radiation: Radiation

Study type

Observational

Funder types

Other

Identifiers

NCT06662929
E-23-7571

Details and patient eligibility

About

The goal of Arabic patient-reported outcome measures during radiotherapy for head and neck cancer is to test the patient-reported outcome measure (PROM) tools. PROM tools are not validated cross-culturally in Arabic-speaking patient populations, which limits their use in our clinical setting. Validation of these PROM tools will allow clinicians to identify the concerns related to our patient population and measure the outcome of our interventions. Main objectives are:

  • To further validate (cross-culture) the PROM instruments related to head and neck cancer (HNC) in Arabic patients.
  • To investigate the prevalence and severity of the patient-reported concerns and their relevance with demographics and clinical characteristics.

The participants will be given tasks to complete 6 tools survey before, during, and after radiotherapy.

Enrollment

125 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 or above and who is planned for receiving and who is currently receiving and who had already received radiotherapy for the HNC at King Saud University Medical City.

Exclusion criteria

  • Individuals who are less than 18 years, presence of debilitating disease (e.g. heart failure) or who lack the capacity to read, understand and sign the informed consent and those.

Trial design

125 participants in 1 patient group

Adult aged 18 years or above, and receiving radiotherapy for the HNC.
Description:
A non-interventional, questionnaire-based cross-sectional study for Arabic-speaking males and females, aged 18 years or above who is planned for receiving and who is currently receiving and who had already received radiotherapy for the Head \& Neck Cancer at King Saud University Medical City.
Treatment:
Radiation: Radiation

Trial contacts and locations

1

Loading...

Central trial contact

Saif A Aljabab, DABR; Abdullah M Alsoghier, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems